Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/30/2012CA2572147C Crystalline forms of (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride
10/30/2012CA2568592C Alkyl substituted indoloquinoxalines
10/30/2012CA2567484C Pyrimidine compounds and their use as modulators of the dopamine d3 receptor
10/30/2012CA2566896C Bicyclic-substituted amines having cyclic-substituted monocyclic substituents for modulating effects of histamine-3 receptor
10/30/2012CA2566297C Substituted cyclohexyl-1,4-diamine derivatives
10/30/2012CA2565889C Oral flora-improving agent, antibacterial agent and growth promoter
10/30/2012CA2565293C Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
10/30/2012CA2561660C Pharmaceutical compositions of pyrimidine-2,4,6-triones
10/30/2012CA2551057C Pentafluorosulfanyl benzoylguanidines, method for their production, their use as medicaments or diagnostic agents and medicament containing the same
10/30/2012CA2549642C Effervescent oral opiate dosage forms and methods of administering opiates
10/30/2012CA2548156C Amine derivatives
10/30/2012CA2541781C 3-hydroxymethyl-4-hydroxy-phenyl derivatives for the treatment of respiratory illnesses
10/30/2012CA2536136C Aryloxy and arylalkyleneoxy substituted imidazoquinolines
10/30/2012CA2528706C Compounds inhibiting the binding of sap for treating osteoarthritis
10/30/2012CA2516449C Bioadhesive liquid composition which is substantially free of water
10/30/2012CA2513280C Acylated 4-amidino- and 4-guanidinobenzylamines for the inhibition plasma kallikrein
10/30/2012CA2512639C Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
10/30/2012CA2510228C 25-so2-substituted analogs of 1.alpha.,25-dihydroxyvitamin d3
10/30/2012CA2498731C .beta.-l-2'-deoxynucleosides for the treatment of resistant hbv strains and combination therapies
10/30/2012CA2482080C Vitamin d compounds for use in improving bone strength in pigs
10/30/2012CA2477101C Use of folates for preventing and treating inflammation and diseases associated with inflammation
10/30/2012CA2474874C Anticholinergic agents, method for producing the same and use thereof as medicaments
10/30/2012CA2467580C Use of lipoxin analogs to promote cell defense against gram-negative infections
10/30/2012CA2466437C Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment
10/30/2012CA2456732C Oral pharmaceutical composition containing a combination of ppar.alpha. and a hmg-coa reductase inhibitor
10/30/2012CA2452074C Surface treatment composition for soft substrates
10/30/2012CA2448302C Lipoxin compounds
10/30/2012CA2445938C Hepatitis c inhibitor tri-peptides
10/30/2012CA2433962C Antibacterial clarithromycin compositions and processes for making the same
10/30/2012CA2230111C Antisecretory factor peptides regulating pathological permeability changes
10/29/2012DE202011109556U1 Eisenhaltige Vitaminzusammensetzung Iron-containing vitamin composition
10/26/2012WO2012145749A1 Pharmacologically optimized multimodal drug delivery system for nordihydroguiaretic acid (ndga)
10/26/2012WO2012145743A1 Microrna-140-5p as a tumor suppressor and sensitizing agent for chemotherapy
10/26/2012WO2012145737A1 Fatty acid amide hydrolase inhibitors for treating
10/26/2012WO2012145728A1 Benzothiazole compounds and their pharmaceutical use
10/26/2012WO2012145723A1 Method for combined conditioning and chemoselection in a single cycle
10/26/2012WO2012145684A1 Transient hypoxia inducers and their use
10/26/2012WO2012145678A1 Anti-cancer and anti-inflammatory parthenolide compounds
10/26/2012WO2012145653A2 Therapeutic combinations for use in neoplasia
10/26/2012WO2012145626A1 Synthetic oligosaccharides for staphylococcus vaccine
10/26/2012WO2012145617A2 Aminopyrimidine kinase inhibitors
10/26/2012WO2012145604A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
10/26/2012WO2012145603A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
10/26/2012WO2012145597A2 Recombinant virus products and methods for inhibition of expression of myotilin
10/26/2012WO2012145582A2 Methods and compositions for the specific inhibitions of egfr by double-stranded rna
10/26/2012WO2012145581A1 Disubstituted octahy-dropyrrolo [3,4-c] pyrroles as orexin receptor modulators
10/26/2012WO2012145575A2 Therapy for leukemia
10/26/2012WO2012145567A1 Antiviral compounds
10/26/2012WO2012145520A2 Carbon monoxide releasing molecules and uses thereof
10/26/2012WO2012145503A1 Pharmaceutical combinations
10/26/2012WO2012145491A2 Composition and method for enhancing an immune response
10/26/2012WO2012145471A1 Insulin-like growth factor-1 receptor inhibitors
10/26/2012WO2012145446A1 Taste-masked formulations of raltegravir
10/26/2012WO2012145392A2 Saccharide conjugates
10/26/2012WO2012145374A1 TARGETING miR-378 FAMILY MEMBERS FOR THE TREATMENT OF METABOLIC DISORDERS
10/26/2012WO2012145330A1 Fluorene-9-bisphenol compounds and methods for their use
10/26/2012WO2012145328A1 Dibenzylphenyl compounds and methods for their use
10/26/2012WO2012145307A1 Method of inhibiting harmful microorganisms and barrier-forming composition therefor
10/26/2012WO2012145281A2 Methods and compositions suitable for preventing and treating hyperleptinemia
10/26/2012WO2012145258A1 Hair loss treatment
10/26/2012WO2012145254A2 Methods of using inhibitors of rorϒt to treat disease
10/26/2012WO2012145236A1 Substituted bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/26/2012WO2012145234A2 Cyclopropyl derivatives and methods of use
10/26/2012WO2012145169A2 Functionalized magnetic nanoparticles and use in imaging amyloid deposits and neurofibrillary tangles
10/26/2012WO2012145129A2 Molecular subtyping, prognosis and treatment of prostate cancer
10/26/2012WO2012145119A2 Low inflammatory blended oils
10/26/2012WO2012145098A1 Use of adenosine a3 receptor agonists for treatment of neuropathic pain
10/26/2012WO2012145069A2 Materials and methods useful to induce cell death via methuosis
10/26/2012WO2012145013A1 Methods for treating or preventing alcohol-related disorders or craving-related disorders
10/26/2012WO2012144964A1 Thiocolchicoside, diclofenac and lansoprazole combinations
10/26/2012WO2012144892A1 Medical use for acidic cannabinoids
10/26/2012WO2012144854A2 Novel uses of licochalcone a
10/26/2012WO2012144752A1 Phenyl-isoxazol derivatives and preparation process thereof
10/26/2012WO2012144661A1 Aromatic heterocyclic derivative having trpv4-inhibiting activity
10/26/2012WO2012144649A1 Method for modulating cytokine activity
10/26/2012WO2012144619A1 Chronic hepatic diseases therapeutic agent for oral administration
10/26/2012WO2012144613A1 Method for producing complex crystal and method for screening complex crystal
10/26/2012WO2012144592A1 Solid pharmaceutical composition
10/26/2012WO2012144560A1 Self-gelatinizable nucleic acid
10/26/2012WO2012144519A1 Granules in liquid dosage form
10/26/2012WO2012144478A1 Tetrahydrothiazepine derivative
10/26/2012WO2012144463A1 Therapeutic agent for tumor
10/26/2012WO2012144405A1 Method for producing adhesive patch, and adhesive patch
10/26/2012WO2012144220A1 Ezh2 as target gene for cancer therapy and diagnosis
10/26/2012WO2012144080A1 Skin barrier function improving agent
10/26/2012WO2012143932A1 Crystalline strontium ranelate form-s
10/26/2012WO2012143879A1 A crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation
10/26/2012WO2012143860A1 Ameliorating cognitive decline
10/26/2012WO2012143856A1 Use of a combination of carotenoid, phytoestrogen and vitamin c for the prevention and/or treatment of pigmentation disorders
10/26/2012WO2012143813A1 Pyrazolospiroketone derivatives for use as acetyl - coa carboxylase inhibitors
10/26/2012WO2012143725A1 Bicyclic heterocycle compounds and their uses in therapy
10/26/2012WO2012143703A1 Dibenzothiazepine derivatives and their use in the treatment of cns disorders
10/26/2012WO2012143660A1 Novel amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome
10/26/2012WO2012143624A2 Acadesine derivatives, products and compositions including same, therapeutic uses thereof, and methods for synthesizing same
10/26/2012WO2012143599A1 Androgen receptor modulating carboxamides
10/26/2012WO2012143576A2 Compounds for preventing, reducing and/or alleviating itchy skin condition(s)
10/26/2012WO2012143526A1 1,4-disubstituted 1,2,3-triazoles, methods for preparing same, and diagnostic and therapeutic uses thereof
10/26/2012WO2012143522A1 Tetrahydropyrazolo [1,5 -a] pyrimidine as anti -tuberculosis compounds
10/26/2012WO2012143510A1 Fluoroalkyl-substituted pyrazolopyridines and use thereof
10/26/2012WO2012143502A1 Composition imitating intraarticular liquid
1 ... 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 ... 7860